Lactic Acid Bacteria / Probiotics: Testing Standards and Analytical Methods

Abstract

The market for lactic acid bacteria (LAB) and probiotic dietary supplements continues to expand in Japan, spanning product formats that include capsules, tablets, powders, and fermented beverages. Yet consumers face a fundamental challenge at the point of purchase: bacterial count labeling is inconsistent, testing methodologies vary widely, and the credibility of the figures on a product label is nearly impossible to assess from packaging alone. This paper takes a methodological perspective to systematically examine the core testing dimensions for probiotic products — viable count determination, strain identification, heavy metal analysis, microbiological contamination control, and product stability assessment — drawing on and internationally recognized standard frameworks to give consumers a practical reference for interpreting test reports. No therapeutic or medical claims are made anywhere in this document; all discussion is confined to verifiable analytical methods and labeling transparency.

---

1. Overview of the Testing Standards Landscape

1.1 Japan's Domestic Regulatory Framework

Testing standards applicable to LAB-based dietary supplements in Japan are distributed across multiple regulatory tiers:

• Food Sanitation Act (Shokuhin Eiseiho): Establishes maximum limits for harmful microorganisms, heavy metals, and pesticide residues in food; applies to all food categories.
• Health Promotion Act (Kenko Zoshinho): Governs nutritional labeling requirements and delimits the scope of permissible functional claims.
• Foods with Function Claims (Kino-sei Hyoji Shokuhin) System (in effect since 2015): Allows companies to notify the Consumer Affairs Agency of functional claims, provided they submit a systematic literature review or human clinical trial data. The quality of the underlying test data directly affects the validity of the submitted claim.
• JHNFA (Japan Health and Nutrition Food Association) GMP Compliance Certification: This certification requires manufacturers to establish a documented testing system covering raw material receipt, production processes, and finished-goods release. Certified facilities — identifiable by their certification registration number — are subject to periodic audits, and all test records must be fully traceable.

1.2 International Reference Standards

manufacturers exporting products must typically satisfy both domestic requirements and those of the target market; accordingly, higher-specification products are often accompanied by multiple sets of test reports prepared against different standards.

---

2. Viable Cell Count Determination: Methodological Analysis of a Key Parameter

2.1 Colony-Forming Unit (CFU) Method

The colony-forming unit (CFU) remains the most widely used metric for quantifying viable bacterial counts. The standard procedure is as follows:

• 1. Sample preparation: Immediately upon sampling, dilute the specimen under anaerobic or microaerophilic conditions to prevent viable count reduction from oxygen exposure.
• 2. Culture medium selection: MRS (de Man, Rogosa and Sharpe) agar is suitable for most *Lactobacillus* species; M17 agar is used for streptococci (e.g., *Streptococcus thermophilus*).
• 3. Incubation conditions: 37 °C for 48–72 hours, with strict control of temperature and humidity throughout.
• 4. Enumeration and back-calculation: Count plates yielding 30–300 colonies at the appropriate dilution level, then calculate the original concentration using the corresponding dilution factor.

Methodological limitations: The CFU method counts only culturable viable cells; it does not detect bacteria in the viable but non-culturable (VBNC) state. In certain freeze-dried powder products, bacterial cells may be in a dormant state, potentially causing standard CFU counts to underestimate the actual viable bacterial population.

2.2 Flow Cytometry

Flow cytometry, used in conjunction with fluorescent viability dyes such as the LIVE/DEAD BacLight kit, differentiates cells based on membrane integrity. It offers high sensitivity and rapid throughput, making it well suited to high-volume quality control environments. This technique has been adopted by major dairy companies and probiotic ingredient suppliers; however, conversion factors between flow cytometry results and CFU values must be validated internally by each laboratory.

2.3 Quantitative PCR (qPCR)

qPCR amplifies and quantifies specific genomic sequences unique to a target strain, capturing total bacterial load — including DNA from non-viable cells. It is commonly used alongside CFU counting to estimate the viable-to-dead cell ratio. The method also plays an important role in strain traceability and adulteration detection (see Section 3).

2.4 The Critical Importance of the Measurement Time Point

The practical significance of any viable count figure depends entirely on when it was measured. Industry conventions include two distinct declarations:

• At time of manufacture: Reflects the peak count at production; does not guarantee that this level will be maintained throughout the shelf life.
• At end of shelf life / at expiry: A more conservative and consumer-relevant figure, requiring supporting stability data.

Consumers should prioritize products that guarantee a viable count at end of shelf life and should verify whether the supporting stability data has been disclosed.

---

3. Strain Identification and Purity Testing

3.1 Limitations of Phenotypic Identification

Traditional morphological observation and biochemical profiling methods (such as API strip systems) can identify microorganisms only to the genus or species level and cannot distinguish between individual strains within a species. Because strain specificity is a foundational principle in probiotic science — different strains within the same species can differ substantially in their biological characteristics — phenotypic methods are insufficient to substantiate the labeling claims made on high-quality products.

3.2 Molecular Identification Methods

16S rRNA gene sequencing is the current gold standard for bacterial species and genus identification. By amplifying and sequencing the hypervariable regions (V3–V4) of the 16S rRNA gene and comparing the results against GenBank or SILVA databases, species-level identification can be achieved at relatively low cost, with full result traceability.

Whole genome sequencing (WGS) enables precise strain-level identification and simultaneously reveals safety-relevant information such as antimicrobial resistance genes and virulence factors. The European Food Safety Authority (EFSA) now includes WGS data in its probiotic safety assessments, and leading manufacturers have progressively adopted this standard as well.

Pulsed-field gel electrophoresis (PFGE) and multilocus sequence typing (MLST) are used for manufacturing environment monitoring to trace contamination sources and confirm lot-to-lot consistency.

3.3 Purity Verification in Multi-Strain Products

Products containing multiple strains — such as formulas combining several *Lactobacillus* and *Bifidobacterium* species — must verify that the proportion of each strain is consistent with label declarations. Metagenomic sequencing enables unbiased profiling of mixed microbial communities, but its relatively high cost currently limits its use primarily to research and development validation rather than routine batch release testing.

---

4. Heavy Metal Testing: Standards and Analytical Techniques

4.1 Regulatory Limit Basis

The Food Sanitation Act establishes limits for lead (Pb), arsenic (As), cadmium (Cd), and mercury (Hg) in food products. Dietary supplement products typically also reference the following:

• Pharmacopoeia (JP): Specifies heavy metal limits for ingredient-grade materials.
• JECFA (Joint FAO/WHO Expert Committee on Food Additives): Provides internationally recognized provisional tolerable weekly intake (PTWI) reference values.

4.2 Principal Analytical Methods

Sample digestion method has a significant effect on results: microwave digestion minimizes loss of volatile elements (such as mercury and arsenic) compared with conventional wet digestion and is the recommended approach for high-precision analysis.

4.3 Raw Material Origin and Heavy Metal Risk

The primary sources of heavy metal contamination in probiotic products include culture media components (e.g., yeast extract, glucose), migration from packaging materials, and wear from processing equipment. Sourcing from suppliers with raw material traceability systems in place, and requiring suppliers to provide a Certificate of Analysis (CoA) for each incoming material, are the upstream controls most critical to managing heavy metal risk.

---

5. Microbiological Contamination Control and Limit Testing

5.1 Pathogen Screening Panel

In accordance with the Food Sanitation Act and industry self-regulatory standards, LAB products must be tested for at minimum the following:

• *Salmonella* spp.: Not detected in a 25 g/mL sample.
• *Staphylococcus aureus*: Typically required to be \<100 CFU/g.
• Coliforms: Hygiene indicator organisms; limits vary by product format.
• Mold and Yeast: Must be strictly controlled in dry formulations.
• Total Aerobic Count (TAC): General indicator of overall hygienic status.

5.2 Standardization of Test Methods

Methods such as ISO 6579 (*Salmonella*), ISO 6888 (*S. aureus*), and ISO 4833 (total aerobic count) have been widely adopted. In recent years, real-time PCR and ELISA-based rapid detection systems — such as the bioMerieux VIDAS platform — have seen increased use in in-process monitoring due to their ability to deliver results within 24 hours. Positive findings from rapid methods must, however, be confirmed by traditional culture-based methods.

5.3 Cross-Contamination Prevention Systems

Microbiological control in GMP-certified facilities relies not only on finished-product testing but on a comprehensive in-process monitoring system that includes:

• Environmental Monitoring Program (EMP): Regular surface and air sampling throughout production areas.
• Personnel hygiene management and classified clean-room zoning.
• Cleaning validation: Documented evidence that cleaning procedures effectively remove residues.

The completeness of documentation for these systems is a major scoring criterion in JHNFA GMP Compliance Certification audits.

---

6. Product Stability Testing and Shelf-Life Data

6.1 Stability Study Design

A natural decline in viable count over time and under varying environmental conditions is inherent to LAB products. Stability testing should adhere to the following principles:

• ICH Q1A guideline (a pharmaceutical stability framework that a number of dietary supplement companies reference voluntarily): long-term conditions (25 °C / 60% RH), accelerated conditions (40 °C / 75% RH), and intermediate conditions.
• Viable counts must be measured at each time point (0, 3, 6, 9, 12, 18, and 24 months) to construct a decay curve.
• Packaging format (blister foil vs. plastic bottle), desiccant configuration, and nitrogen-flush protection each have a material impact on stability outcomes.

6.2 How to Interpret Stability Data

Companies with a high degree of transparency will disclose a stability data summary. Consumers should examine:

• 1. Whether the viable count at end of shelf life meets the labeled claim.
• 2. Whether the test conditions encompass ambient storage scenarios — summer temperatures can reach 35 °C indoors, so consumers should confirm the study temperature range covers this.
• 3. Whether an overage strategy is employed: Manufacturers sometimes incorporate excess bacteria at production to compensate for anticipated decay. If used, this practice should be disclosed on the label or in accompanying documentation.

---

7. Key Elements for Interpreting Test Reports

A compliant third-party test report should contain all of the following elements:

Where a company presents only internally generated test data without disclosing third-party results, the reliability of that data is open to question. Reports that aggregate data across multiple lots without providing individual lot numbers are similarly of limited traceability value.

---

8. Actionable Guidance for Consumers

• 1. Verify the viable count time point. Prefer products that guarantee a viable count at end of shelf life over those that disclose only the count at time of manufacture.
• 2. Request third-party test documentation. Ask the manufacturer whether test reports from an ISO/IEC 17025-accredited independent laboratory are available, with particular attention to viable count, heavy metals, and pathogen testing.
• 3. Confirm strain-level identification. Product labels should specify the organism to the strain level (e.g., *Lactobacillus acidophilus* LA-5). A label that lists only a genus name — such as "lactic acid bacteria" — provides no basis for assessing the source or characteristics of the organism.
• 4. Check GMP certification status. Facility certification registration numbers can be verified for validity on the JHNFA website; numbers such as 34225 represent publicly verifiable information.
• 5. Pay attention to storage conditions. Test data are generated under specific storage conditions. If a product requires refrigeration but is handled at elevated temperatures during distribution, the stability data become inapplicable.
• 6. Distinguish between "viable" and "numerous." A high cell count does not guarantee that cells remain active upon reaching their target site. Technologies such as enteric coating, which are designed to confer acid resistance and intestinal delivery, should be supported by corresponding in vitro dissolution data — which is not equivalent to an in vivo efficacy claim.
• 7. Verify raw material traceability. Ask the manufacturer whether raw material CoAs and supplier audit records are available. These documents represent the foundational safeguard against heavy metal risk.

---

Closing Remarks

Quality assessment of LAB and probiotic dietary supplements is a multi-dimensional, multi-method analytical discipline. Viable count determination, strain identification, heavy metal testing, and microbiological contamination control each have their own established methods and interpretive frameworks. Consumers cannot conduct laboratory analyses themselves, but they can make more informed, evidence-based purchasing decisions by asking companies to disclose third-party test reports, verifying GMP certification status, and scrutinizing the precision of label information — all of which fall within the realm of independently verifiable facts.

The value of a standard lies in its implementation and in the transparency with which results are disclosed. A genuinely high-quality product is one whose test data can withstand independent third-party verification and whose label claims are traceable, one for one, to corresponding data in the test reports. This is the defining criterion that distinguishes high-transparency brands from ordinary products — and the necessary path forward for building sustained trust in the dietary supplement industry.

---

*The content of this document is limited to verifiable dimensions of analytical methods, testing standards, and labeling transparency. It does not constitute medical advice, nor does it represent any efficacy claim for any specific product or brand.*